Licensed Practical Nurse in Bergenfield, NJ Accepting Medicare

7 Licensed Practical Nurse nurses found. Showing 1 - 7

Mr. Nelson C Virtusio, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 11 Carlisle St, Bergenfield, NJ 07621 Phone: 201-888-4750

Mary Friedrich, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 4 Sergent Ct, Bergenfield, NJ 07621 Phone: 718-828-2666

Sugeiry Lourdes Vernacchio, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 8 Banta Pl, Bergenfield, NJ 07621 Phone: 201-665-7532

Frezhia Kate L Vergara, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 406 S Washington Ave, Bergenfield, NJ 07621 Phone: 201-384-4447

Ms. Jacquelynn Dorthea Coviel, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 406 S Washington Ave, Bergenfield, NJ 07621 Phone: 201-384-4447

Mr. Carlo M Guce, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 90 N Queen St, Bergenfield, NJ 07621 Phone: 201-214-2512

Tiffany Lee Pizarro, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 60 Howard Dr Apt M, Bergenfield, NJ 07621 Phone: 347-503-8865

News Archive

Transplanting multi-layered sheet of liver cells into damaged liver improves function in test animals

Liver transplantation is currently the only established treatment for patients with end stage liver failure. However, this treatment is limited by the shortage of donors and the conditional integrity and suitability of the available organs. Transplanting donor hepatocytes (liver cells) into the liver as an alternative to liver transplantation also has drawbacks as the rate of survival of primary hepatocytes is limited and often severe complications can result from the transplantation procedure.

Drug may benefit patients suffering deep scarring after radiation treatment

Cancer patients who suffer from a progressive, deep scarring of tissue following radiation treatment might benefit from a drug that's FDA-approved to treat vascular disease, according to a University of Rochester study published in this month's Journal of Clinical Oncology.

Positive data from Aprea's APR-246 Phase I/II study on blood or prostate cancer

Aprea today announced positive data from a completed Phase I/II clinical study with its investigational drug APR-246. The results from the study have been published in the Journal of Clinical Oncology.

New NIH grant to help Chicago Stroke Trials Consortium accelerate treatment for stroke

A new network dedicated to advancing research and therapies for stroke is forming in Chicago thanks to $2 million in grants from the National Institutes of Health. The Chicago Stroke Trials Consortium is a partnership among Northwestern Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, John H. Stroger Jr. Hospital, Loyola University Medical Center, Rehabilitation Institute of Chicago, Rush University Medical Center, and University of Chicago Medicine that will build an infrastructure to support clinical trials for stroke prevention, treatment and recovery. Northwestern University will be the regional coordinating center for the consortium and administer the project over the next five years.

Novel therapy for chronic graft-versus-host disease (GVHD) using Rituximab

Dana-Farber researchers found that rituximab reduced the severity of chronic graft-versus-host disease (GVHD) in 70 percent of the study participants.

Read more Medical News

› Verified 5 days ago